有机碲Ylide反应Ⅻ用碲Ylide合成双环丙烷衍生物

由相应的碲盐生成的某些碲ylide,能顺利地和1,4-双(3-取代苯基-3-酮-1-丙烯基)苯,1,5-二取代苯基-1,4-戊二烯-3-酮反应生成双环丙烷衍生物,反应具有高立体选择性,产率为61.8-88.8％。     

用碲Ylide合成杂环取代环丙烷衍生物

本文报道了由碲盐和杂环取代查尔酮反应合成杂环取代环丙烷衍生物的简便方法。     

应用芳基锂合成查尔酮

苯基锂、2-甲氧基苯基锂和2,4-二甲氧基苯基锂分别与肉桂酸反应以相当好的收率生成相应的查尔酮;2,6-二甲氧基苯基锂与肉桂酸不发生反应,但能与肉桂酸甲酯反应生成2',6'-二甲氧基查尔酮;类似的还制得了2',4',6'-三甲氧基查尔酮和2',4',4,6'-四甲氧基查尔酮.2,4-二甲氧基苯基锂和2,4,6-三甲氧基苯基锂也能与γ-丁酸内酯反应分别生成γ-羟丙基-(2,4-二甲氧基苯基)酮和γ-羟丙基-(2,4,6-三甲氧基苯基)酮.没发现三级醇生成.     

有机碲氧化物催化合成α,β-不饱和酮和2,4-二烯酮

α,β-不饱和酮是重要的有机合成中间体,常用醇钠或氢氧化钠作催化剂由醛酮缩合合成,这时常由于强碱而发生副反应。Cava曾报道双对-甲氧苯基氧化碲(BMPTO)对醇醛缩合有一定催化作用。本文以BMPTO为催化剂,通过Claisen-Schmidt反应合成了一系列α,β-不饱和酮和2,4-二烯酮。所得产物及其结构表征结果列于表1。     

1-甲基-2-苯基吲哚的琥红敏化单重态氧反应

1-甲基-2-苯基吲哚(1)在甲醇中的琥红(RB)敏化单重态氧反应生成1-甲基-2-甲基氧-2-苯基-1, 2-二氢-3H-吲哚-3-酮(4)和1-甲基-2-羟基-2-苯基-1, 2-二氢-3H-吲哚-3-酮(6), 后者在强碱性介质下发生苯乙醇酸型重排生成1-甲基-3-羟基-3-苯基氧化吲哚(14)。研究了6的溶剂分解反应以及外加碱对光氧化反应的影响。探讨了光氧化产物的形成途径。结果表明: 4系两性离子中间体2的溶剂捕获、脱水产物, 而6则系二氧杂环丁烷中间体7的裂解、抽氢产物。     

3-苯基-4-氯-1,3,4-二氮磷杂环戊-2-硫酮的合成及其除草活性研究

报道了苯基硫脲与脂肪醛(酮)及三氯化磷进行的类Mannich反应,除生成预期产物3-苯基-4-氯-4-氧代-1,3,4-二氮磷杂环戊-2-硫酮(Ⅰ)外,还生成了少量3-苯基-4-氯-4-硫代-1,3,4-二氮磷杂环戊-2-硫酮(Ⅱ).当Ⅰ与Lawesson试剂在甲苯中反应时,可顺利地转化为Ⅱ.生物测定结果表明,Ⅱ具有较好的选择性除草活性.晶体结构测定表明,Ⅱ的五元磷杂环为平面结构.     

含肟醚的新型四唑啉酮衍生物的合成及除草活性研究

1-(4-氯苯基)-1,4-二氢-四唑-5-酮(1)与氯丙酮反应生成1-(4-氯苯基)-4-(2-氧代丙基)-1,4-二氢-四唑-5-酮(2). 中间体2、盐酸羟胺和卤化物通过三组分一锅法合成了目标化合物3. 初步生物活性测试结果表明: 目标化合物3具有较好的除草活性.     

2-甲基-6-溴苯并碲唑及其衍生菁染料的合成

以对溴苯胺为原料,经汞化、酰化,再与四氯化碲发生亲电取代反应生成2-乙酰氨基-5-溴苯基三氯化碲(内盐);后者以硼氢化钠还原、浓盐酸关环,用碳酸氢钠中和后即得关键中间体2-甲基-6-溴苯并碲唑。苯并碲唑经碘甲烷或碘乙烷季铵化后,用原甲酸三乙酯缩合制得相应的对称染料2,2'-二甲基-5,5'-二溴碲碳菁碘盐和2,2'-二乙基-5,5'-二溴碲碳菁碘盐。测定了它们的可见吸收光谱。     

合成α,β-不饱和酮的一种简便方法——O,O-二乙基磷酰碲钠作用下ω-溴代苯乙酮与芳醛的反应

在○,○-二乙基磷酰碲钠存在下,ω-溴代苯乙酮与芳醛于乙醇中反应,以良好产率生成α,β-不饱和酮。     

3-(N-取代苯基-2-乙酰胺基)硫基-4-N-取代邻羟苯基亚胺基-5-甲基-1,2,4-三唑类化合物的合成及生物活性研究

以对称二氨基硫脲为原料,与冰醋酸反应生成5-甲基-4-氨基-1,2,4-三唑-3-硫酮(1);在弱酸性条件下,1与取代水杨醛反应生成席夫碱中间体5-甲基-4-(N-取代邻羟苯基)亚胺基-1,2,4-三唑-3-硫酮(2a～2c);最后在碱性条件下分别与N-取代苯基-2-氯乙酰胺发生烷基化反应生成15种未见报道的目标化合物3-(N-取代苯基-2-乙酰胺基)硫基-4-(N-取代邻羟苯基)亚胺基-5-甲基-1,2,4-三唑(3a～3o),其结构经IR,1H NMR,13C NMR确证.初步生物测试表明,质量分数为0.01%时,3a～3o对白色念珠菌的抑菌率均达90%以上,具有很强的抑菌活性;对金黄色葡萄球菌、大肠杆菌的抑菌率达80%以上,具有较强的抑菌活性.     

7-Trifluoromethyl-5-phenyl-2-oxo-(1H)-oxazolo[5,4-b]pyridine and some of its properties

The potassium salt of 7-trifluoromethyl-5-phenyl-2-oxooxazolo[5, 4-bjpyridine (IV) was prepared from 3-aminocarbonyl-4-trifluoromethyl-6 phenyl-2(1H)-pyridone by the Hofmann reaction and was converted into 3-anuno-4-trifluoromethyl-6-phenyl-2(1H)-pyridone without isolation. 1-Substituted 7-trifluoromethyl-5phenyl-2-oxooxazolo[5, 4-b]pyridines were formed by alkylation of salt IV. 6-Halogeno-7-trifluoromethyl-S phenyl-2-oxo(1H)-oxazolo[5,4-b]pyridines have been prepared.Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 4, pp. 542–545, April. 1996.     

Darstellung,Eigenschaften und Kristallstruktur von [2-(1′-methyl-4-imidazolyl)phenyl-1-C,3′-N]acetylacetonatopalladium(II)

Synthesis, Properties, and Structure of [2-(1′-methyl-4-imidazolyl)phenyl-1-C,3′-N]-palladium(II) Acetylacetonate The reaction of Di-μ-chloro-bis[2-(1′-methyl-4-imidazolyl)phenyl-1-C,3′-N]palladium(II) with Thallium(I) acetylacetonate yields [2-(1′-methyl-4-imidazolyl)phenyl-1-C,3′-N]palladium(II) acetylacetonate. The complex crystallizes monoclinic in the space group P2₁/n with the lattice constants a = 1302.4(3), b = 836.0(2), c = 1341.3(3) pm, β = 93.69(3)°. Pd has a squareplanar coordination by two O atoms of acetylacetonate, the N atom of the imidazole ring, and the C atom of the phenyl group. I.r., n.m.r., and mass spectra are reported.     

几种取代胡椒醛缩合不对称卟啉化合物的合成及结构表征

利用微波加热法, 以6-硝基胡椒醛、两种R取代苯甲醛(R＝H, Cl)、吡咯为原料, 在丙酸中缩合, 合成了两种新的不对称卟啉化合物5-(2-硝基-4,5-亚甲二氧基)苯基-10,15,20-三苯基卟啉(2)和5-(2-硝基-4,5-亚甲二氧基)苯基-10,15, 20-三对氯苯基卟啉(3). 将2和3还原得到了化合物5-(2-氨基-4,5-亚甲二氧基)苯基-10,15,20-三苯基卟啉(4)和5-(2-氨 基-4,5-亚甲二氧基)苯基-10,15,20-三对氯苯基卟啉(5). 新化合物结构分别经UV-Vis, IR, ¹H NMR及元素分析所证实. 荧光测试表明, 几个化合物都有比较好的荧光强度, 且氨基取代化合物的荧光强度比相应的硝基化合物的大.     

Complexing between copper(II) and bulky substituted 3-benzoyl thioureas in copper(II) hexacyanoferrate(II) gelatin-immobilized matrix systems

A novel route to complexes of CuII with various bulky substituted 3-benzoylthioureas: [(1-(2-hydroxy)phenyl-, 1-(4-hydroxy)phenyl-, 1,1-dibenzyl-, 1-methyl-1-phenyl-, 1-N-pentamethylene-] and 1-N-3-oxatetramethylene-3-benzoylthiourea, complexed to a CuII hexacyanoferrate- (II) gelatin-immobilized matrix in contact with aqueous alkali (pH 12.0) solutions of the ligands indicated, has been developed. Under the conditions specified, coordination of each ligand is preceded by decomposition of CuII-hexacyanoferrate(II) to give polymeric copper(II) hydroxide under the influence of OH– ions. With CuII-1-(4-hydroxy)phenyl-3-benzoylthiourea, three different water-insoluble coordination compounds are formed; in the other CuII-ligand systems, two types of complexes are formed, whereas complexing in solution or solid phase in these systems results, as a rule, in the formation of only one coordination compound. In systems such as CuII-1-naphthyl-3-benzoylthiourea, CuII-1-(4-hydroxy-3,5-di-t-butyl)benzyl-3-benzoylthiourea and CuII-1-(4-hydroxy-3,5-di-t-butyl) phenethyl-3-benzoylthiourea, complexing in CuII hexacyanoferrate(II) gelatin-immobilized matrices (GIM) is not observed.     

取代吡唑啉衍生物的合成与生物活性

采用α-三唑-β-烷氧基芳酮与肼关环,制备了1,3-二苯基-4-三唑基吡唑啉1a,1-苯基-3-对氯苯基-4-三唑基吡唑啉1b和3-取代苯基-4-三唑基吡唑啉(7),并研究了化合物7的成环优化条件.使用α,β-不饱和酮与肼关环合成了1,3,4,5-多取代吡唑啉衍生物1c-1h,并初步用质谱法确定了该反应产物的结构;同时,以3,5-二取代吡唑啉(6)和7作为中间体合成了1-,3-,4-或5-取代的化合物2a-2l.初步生物活性测定结果表明,所合成的化合物均有一定的杀菌、激素和除草效果.     

Synthesis of 3-carboethoxy-4,11-dihydro-11-alkyl/phenyl-4-oxopyrimido[1,2-b][1,2,4]benzothiadiazine 6,6-dioxides. A novel heterocyclic ring system

The synthesis of some novel 3-carboethoxy-4,11-dihydro-11-alkyl/phenyl-4-oxopyrimido[1,2-b][1,2,4]benzo-thiadiazine 6,6-dioxides ( IVa-c ) from 3-amino-4-alkyl/phenyl-4H-1,2,4-benzothiadiazine 1,1-dioxides ( 1a-c ) and diethyl ethoxymethylenemalonate ( II ) is described. The compounds have been screened for their antibacterial activity.     

Synthesis and reactions of 4-(arylhydrazino)coumarins

The interaction of 4-hydroxycoumarin with phenyl-, 2-chlorophenyl- and 4-bromophenyhydrazine hydrochlorides in the presence of triethylamine led in all cases to the corresponding 4-(arylhydrazino)-coumarins and 1-aryl-3-(2-hydroxyphenyl)-2H-pyrazolin-5-ones. 4-(Arylhydrazino)coumarins reacted with 4-chlorobenzaldehyde in the presence of piperidine acetate to give the corresponding 2-aryl-3-(4-chlorophenyl)[1]benzopyrano[4,3-b]pyrazol-4-ones. The reaction of 4-(4-bromophenylhydrazino)-coumarin with 4-chlorobenzaldehyde in the presence of piperidine acetate and an excess of piperidine gave 2-(4-bromophenyl)-5-(4-chlorophenyl)-3-(2-hydroxyphenyl)-4-(piperidinocarbonyl)pyrazole, but the reaction of phenyl- and 4-(2-chlorophenylhydrazino)coumarins with 4-chlorobenzaldehyde gave 1-aryl-5-(4-chlorophenyl)-3-(2-hydroxyphenyl)-4-(1-piperidino)carbonyl-4,5-dihydropyrazoles.     

Synthesis,spectral, and thermal studies of oxomolybdenum(V) Schiff-base complexes derived from heterocyclic β-diketone

Six mononuclear Mo(V) Schiff-base complexes were prepared by the reaction of MoCl₅ with Schiff bases, namely HL¹–HL³ and HL⁴–HL⁶, such as 5-hydroxy-3-methyl-1(2-chloro)phenyl-1H-pyrazolone-4-carbaldehyde (I), 5-hydroxy-3-methyl-1(3-chloro)phenyl-1H-pyrazolone-4-carbaldehyde (II), and 5-hydroxy-3-methyl-1(3-sulfoamido)phenyl-1H-pyrazolone-4-carbaldehyde (III) with ethanolamine and propanolamine, respectively, in aqueous ethanolic medium. The resulting complexes have been characterized by elemental analyses, molar conductance, FT-IR, ¹H-NMR, electronic, electron spin resonance (ESR) spectra, magnetic susceptibility, and thermal study. The molar conductivity data show them to be non-electrolytes. IR and ¹H-NMR spectral data suggest that the ligand is a dibasic bidentate with ON donor toward metal ion. Electronic, magnetic, and ESR spectral data suggest that the oxomolybdenum(V) complexes have distorted octahedral geometry. One chloride coordinated to molybdenum is confirmed by thermal study.     

新型苯并二氢呋喃合二酮酸类化合物的合成及其与整合酶分子对接研究

以阿魏酸甲酯为原料,通过氧化偶联构建2-芳基苯并二氢呋喃骨架,再经傅克酰基化和酯缩合反应依次制得(E)-3-［2-(4-羟基-3-甲氧基-5-乙酰基)苯基-3-甲氧羰基-7-甲氧基-2,3-二氢苯［b］并呋喃-5-基］丙烯酸甲酯（3）和(E)-3-［2-(4-羟基-3-甲氧基-5-甲氧羰基乙酰基)苯基-3-甲氧羰基-7-甲氧基-2,3二氢苯并［b］呋喃-5-基］丙烯酸甲酯（4）; 4经水解反应合成3-【2-羟基-3-甲氧基-5-｛5-［2-（甲氧基羰基）乙烯基］-7-甲氧基-3-甲氧羰基-2,3-二氢苯并［b］呋喃-2-｝基】苯基-3-氧丙酸（5）,化合物3~5未见文献报道,其结构经¹H NMR, ¹³C NMR和MS(ESI)表征。采用分子对接软件Autodock vina对化合物2~5与HIV-1整合酶核心部位高度同源的PFV IN（PDB: 3L2V）进行对接,计算结果显示该类化合物能与整合酶形成稳定的复合物,具有1,3-二酮基团的化合物3, 4和5能与整合酶中金属离子产生螯合作用,其中化合物5的结合作用最强。     

Reaction of ethyl 3-ethoxymethylene-2,4-dioxovalerate with monosubstituted hydrazines

Reactions of ethyl 3-ethoxymethylene-2,4-dioxovalerate (1) with phenyl- and methylhydrazines are described. While the reaction of 1 with phenylhydrazine gave a mixture of ethyl 4-acetyl-1-phenylpyrazole-5-carboxylate (4) and ethyl 5-methyl-1-phenylpyrazole-4-glyoxylate (5), 1 reacted with methylhydrazine to give ethyl 4-acetyl-1-methylpyrazole-3-carboxylate (14) as the sole product.